Bethanechol is a medication used to treat urinary retention and other bladder-related issues. It is a cholinergic agonist, meaning it stimulates the muscarinic receptors found in the bladder, leading to increased bladder contractions and improved bladder emptying. This medication is generally well-tolerated and has few side effects, but there are some potential adverse effects that are not widely known. In this article, we will explore the potential adverse effects of bethanechol and discuss ways to minimize their occurrence.
Bethanechol is a synthetic medication used to treat urinary retention and other bladder-related issues. It is a cholinergic agonist, meaning it stimulates the muscarinic receptors found in the bladder, leading to increased bladder contractions and improved bladder emptying. It is generally well-tolerated and has few side effects, but there are some potential adverse effects that are not widely known.
The most commonly reported side effects of bethanechol include nausea, vomiting, abdominal pain, diarrhea, and headache. It can also cause an increase in heart rate and blood pressure. More serious side effects have been reported, including allergic reactions, chest pain, difficulty breathing, and irregular heartbeat. It is important to note that these side effects are rare and usually occur in patients taking higher doses of the medication.
Bethanechol can also cause anticholinergic side effects, which are caused by its ability to block the action of the neurotransmitter acetylcholine. These side effects include dry mouth, blurred vision, confusion, and difficulty urinating. These side effects are usually mild and go away when the medication is discontinued.
The most important way to minimize the potential adverse effects of bethanechol is to take the medication exactly as prescribed by your doctor. Do not take more or less than the prescribed dose, and do not take it for longer than recommended. Additionally, make sure to tell your doctor about any other medications you are taking, as some medications can interact with bethanechol and increase the risk of side effects.
It is also important to be aware of the potential side effects of bethanechol and to contact your doctor if you experience any of them. This is especially important if you experience chest pain, difficulty breathing, or other serious side effects. Finally, drinking plenty of fluids and eating a balanced diet can help to minimize the side effects of bethanechol.
Bethanechol is a medication used to treat urinary retention and other bladder-related issues. It is generally well-tolerated and has few side effects, but there are some potential adverse effects that are not widely known. These include nausea, vomiting, abdominal pain, diarrhea, headache, increased heart rate and blood pressure, and anticholinergic side effects. To minimize the potential adverse effects of bethanechol, it is important to take the medication exactly as prescribed, be aware of the potential side effects, and contact your doctor if any of them occur. Additionally, drinking plenty of fluids and eating a balanced diet can help to minimize the side effects of bethanechol.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation